Atul Pande, M.D
Atul Pande has a broad experience in strategic enterprise leadership of R&D with proven results as demonstrated by successful regulatory filings and approvals of new drugs.
Dr. Pande has experience in Neurosciences, Respiratory, HIV, Oncology and Cardiovascular therapy areas.
Suggested For You
whitepaper
December 17th, 2025
Estimands: Opportunity or Risk for Drug Developers?
case study
December 10th, 2025
From Challenge to Confidence: How MMS Delivered 800+ High-Quality Narratives in Record Time
case study
December 5th, 2025
How MMS Enabled the Use of External Controls to Accelerate a COVID 19 Proof of Concept Trial
news
December 4th, 2025
Former FDA, CRO, and Industry Leader Dr. Stephine Keeton Joins MMS as Senior Director of Biometrics
case study
December 4th, 2025
How MMS Modernized Pulmonary Data Models to Streamline Clinical Analysis and Improve Decision-Making
perspectives
December 2nd, 2025
What AI Singularity Could Mean for the Future of Clinical Biometrics
case study
December 1st, 2025
Expert Support for Regulatory Briefing Books that Strengthen Sponsor Defense Strategies
case study
November 28th, 2025
How MMS Scaled Biostatistics Expertise to Accelerate a High Priority Vaccine Program
case study
November 24th, 2025
Regulatory Expertise that Strengthens Global Market Success
whitepaper
November 21st, 2025
The Chief Medical Officer’s Investor Playbook
case study
November 19th, 2025
How MMS Supported IDMC Operations to Ensure Integrity and Safety in a High Complexity COVID 19 Trial
perspectives
November 18th, 2025
The Role of AI in Transforming Medical Writing